http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1116176-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_500347adee55c7fc2c6c36704e490ca8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2015-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e6ee62972b71e540c528a850124fb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8917fc03a22f3301c6f14de87c7a260
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4c7a55e4a181c1c9b94e7d022ac45f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b4c3793c20917b80edfdfcc4b4746a
publicationDate 2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1116176-T1
titleOfInvention 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing them
abstract The present invention relates to (R, S) 2-aryl-propionic acids and derivatives, their individual enantiomer (S), and to pharmaceutical compositions containing them, which are used in the prevention and treatment of tissue damage due to deteriorated recruitment of polymorphonuclear neutrophils. (PMN leukocytes) at sites of inflammation. The present invention provides compounds for use in the treatment of transient cerebral ischemia, polymorphic pemphigoid, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis, and lesions caused by ischemia and reperfusion.
priorityDate 2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032

Total number of triples: 27.